2,2,5-Trimethyl-5-pentylcyclopentan-1-one
Common Name: |
2,2,5-Trimethyl-5-pentylcyclopentan-1-one |
IUPAC Name: |
2,2,5-trimethyl-5-pentylcyclopentan-1-one |
Molecular Formula: |
C13H24O |
SMILES: |
CCCCCC1(CCC(C1=O)(C)C)C |
Inchi: |
1S/C13H24O/c1-5-6-7-8-13(4)10-9-12(2,3)11(13)14/h5-10H2,1-4H3 |
Inchi Key: |
PUKWIVZFEZFVAT-UHFFFAOYSA-N |
Cas No: |
65443-14-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
196.33 |
Mass (g/mol) |
196.183 |
Molar Refractivity |
62.17 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
247.16 |
Vapor Pressure (mmHg@25.00 °C) |
0.026 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.92 |
LogP |
3.962 |
iLOGP |
3.02 |
XLOGP3 |
4.24 |
WLOGP |
3.96 |
MLOGP |
3.15 |
ESOL Log S |
-3.46 |
ESOL Solubility (mg/ml) |
0.067 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.31 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.31 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.49 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.703 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.368 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |